Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02968212 · ClinicalTrials.gov registry record · Phase 2
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)
A Phase 2 study of Mycobacterium Avium Complex, sponsored by Oregon Health and Science University.
- Active
- Registry status
- Phase 2
- Development phase
- 102
- Enrollment target
- 7
- Study locations
NCT02968212: Active Phase 2 study of Mycobacterium Avium Complex, sponsored by Oregon Health and Science University.
NCT02968212 is a Phase 2 study of Mycobacterium Avium Complex that is active but no longer recruiting, run by Oregon Health and Science University. The registered enrollment target is 102 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (23% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02968212, a Phase 2 study of Mycobacterium Avium Complex, is active but no longer recruiting, sponsored by Oregon Health and Science University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 102 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to evaluate the clinical effectiveness and safety of clofazimine when used to treat Mycobacteria avium complex (MAC) lung disease. Funding Source - FDA OOPD
Conditions Studied
Interventions
- DRUG Clofazimine
- OTHER sugar pill
Study Locations (7)
Colorado
- National Jewish Health - Denver
Florida
- University of South Florida - Tampa
Illinois
- University of Chicago - Chicago
Louisiana
- Louisiana State University - Baton Rouge
Maryland
- National Heart, Lung and Blood Institute - Bethesda
Oregon
- Oregon Health & Science University - Portland
Texas
- University of Texas Health Science Center - Tyler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2017-04-11 |
| Est. Completion | 2026-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02968212
The ClinicalTrials.gov registry entry for NCT02968212 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (23% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mycobacterium Avium Complex appearing as the primary indexed condition, and to 2 interventions - of which Clofazimine is the first listed.
NCT02968212 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Colorado, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT02968212 about?
NCT02968212 is a clinical study titled "Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)". The purpose of this study is to evaluate the clinical effectiveness and safety of clofazimine when used to treat Mycobacteria avium complex (MAC) lung disease. Funding Source - FDA OOPD
What is the current status of trial NCT02968212?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 102 participants. The study started on 2017-04-11. Estimated completion is 2026-03.
What conditions does trial NCT02968212 study?
This clinical trial studies the following conditions: Mycobacterium Avium Complex.
What interventions are being tested in trial NCT02968212?
The interventions under investigation include: Clofazimine (DRUG), sugar pill (OTHER).
Who is sponsoring clinical trial NCT02968212?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02968212 being conducted?
This trial has 7 study locations across Colorado, Florida, Illinois, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mycobacterium Avium Complex
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.